The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
Open accessAbstract
Background Gut microbiota is emerging as a novel risk factor for atherothrombosis, but the predictive role of gut‐derived lipopolysaccharide ( LPS ) is unknown. We analyzed (1) the association between LPS and major adverse cardiovascular events ( MACE ) in atrial fibrillation ( AF ) and (2) its relationship with adherence to a Mediterranean diet (Med‐diet). Methods and Results This was a prospective single‐center study including 912 AF patients treated with vitamin K antagonists (3716 patient‐years). The primary end point was a composite of MACE . Baseline serum LPS , adherence to Med‐diet (n=704), and urinary excretion of 11‐dehydro‐thromboxane B 2 (TxB 2 , n=852) were investigated. Mean age was 73.5 years; 42.9% were women. A total of 187 MACE (5.0% per year) occurred: 54, 59, and 74 in the first, second, and third tertile of LPS , respectively (log‐rank test P =0.004). Log‐ LPS (hazard ratio 1.194, P =0.009), age (hazard ratio 1.083, P <0.001), and previous cerebrovascular (hazard ratio 1.634, P =0.004) and cardiac events (hazard ratio 1.822, P <0.001) were predictors of MACE . In the whole cohort, AF (versus sinus rhythm) (β 0.087, P =0.014) and low‐density lipoprotein cholesterol (β 0.069, P =0.049) were associated with circulating LPS . Furthermore, Med‐diet score (β −0.137, P <0.001) was predictive of log‐ LPS , with fruits (β −0.083, P =0.030) and legumes (β −0.120, P =0.002) negatively associated with log‐ LPS levels. Log‐ LPS and log‐TxB 2 were highly correlated (r=0.598, P <0.001). Log‐ LPS (β 0.574, P <0.001) and Med‐diet score (β −0.218, P <0.001) were significantly associated with baseline urinary excretion of TxB 2 . Conclusions In this cohort of AF patients, LPS levels were predictive of MACE and negatively affected by high adherence to Med‐diet. LPS may contribute to MACE incidence in AF by increasing platelet activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a recent observational study, circulating LPS concentrations were predictive of MACE in a cohort of patients with atrial fibrillation, suggesting that endotoxin translocation impacts CVD complications27.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,825
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422
(2001) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2001.tb01222.x · Cited by 3,515
Christiane, Druml, Wolzt, & Pleiner (2001) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 3,419
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
Task Force Members, Thygesen, K. A., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,536
Cited by
Sorted by citations
Items 101–181 of 181
Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases
Usman, I., Anwar, A., Shukla, S., & Pathak, P. (2024) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x310857240607103028 · Cited by 12
Role of the Endocannabinoidome in Human and Mouse Atherosclerosis
Piscitelli, F., & Silvestri, C. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190826162735 · Cited by 13
Probiotics, gut microbiome, and cardiovascular diseases: An update
Dosh, L., Ghazi, M., Haddad, K., Masri, J. E., Hawi, J. S., Leone, A., Basset, C. A., Geagea, A. G., Jurjus, R. A., & Jurjus, A. R. (2024) · Transplant Immunology · doi:10.1016/j.trim.2024.102000 · Cited by 11
Keirns, B. H., Medlin, A. R., Maki, K. A., McClanahan, K., Fruit, S. E., Sciarrillo, C. M., Hart, S. M., Joyce, J. M., Lucas, E. A., & Emerson, S. R. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00381.2024 · Cited by 11
Bikov, A., Dragonieri, S., Csoma, B., Mazzuca, C., Finamore, P., Rocchi, G., Putignani, L., Guarino, M. P. L., & Scarlata, S. (2022) · Microorganisms · doi:10.3390/microorganisms10122457 · Cited by 11
Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies
Al‐Kaisey, A., Figgett, W. A., Hawson, J. J., Mackay, F., Joseph, S., & Kalman, J. M. (2023) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2022.33 · Cited by 11
Ni, W., Sun, Y., Qiu, T., Liu, J., Cao, Y., Zang, T., Fan, X., Bai, J., Huang, J. Z., & Liu, Y. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168292 · Cited by 11
Chen, H., Zhang, L., Li, Y., Meng, X., Chi, Y., & Liu, M. (2024) · Aging and Disease · doi:10.14336/ad.2024.0538 · Cited by 11
Jing, K., Yang, J., He, C., Zhou, B., Fang, S.-Q., Salinas, M. G., Mohabbat, A. B., Bauer, B. A., & Wang, X. (2024) · Apmis · doi:10.1111/apm.13473 · Cited by 10
Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved?
Laudani, S., Godos, J., Romano, G. L., Gozzo, L., Domenico, F. D., Azpíroz, I. D., Diaz, R. M., Giampieri, F., Quiles, J. L., Battino, M. A., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17020236 · Cited by 10
Quirk, A. R., Schifferer, J. K., Maki, K. A., Robinson, A. T., & Keirns, B. H. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00120.2025 · Cited by 9
Gawalko, M. M., Kociemba, W., Sanders, P., & Linz, D. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2570423 · Cited by 10
Human microbiome and cardiovascular diseases
Alam, J., Puppala, V., Uppulapu, S. K., Das, B., & Banerjee, S. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.012 · Cited by 11
Gut Microbiome and Its Role in Valvular Heart Disease: Not a “Gutted” Relationship
Nayak, G., Dimitriadis, K. S., Pyrpyris, N., Manti, M., Kamperidis, N., Kamperidis, V., Ziakas, A., & Tsioufis, K. P. (2024) · Life · doi:10.3390/life14040527 · Cited by 9
Non-Coding RNAs and Gut Microbiota in the Pathogenesis of Cardiac Arrhythmias: The Latest Update
Suga, N., Ikeda, Y., Yoshikawa, S., Taniguchi, K., Sawamura, H., & Matsuda, S. (2023) · Genes · doi:10.3390/genes14091736 · Cited by 7
New Promising Targets for Imaging in Cardiovascular Diseases
Ståhle, M. R., Popescu, C. E., Rischpler, C., Zhang, H., Massalha, S., Lopes, L. R., Rominger, A., & Caobelli, F. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.05.006 · Cited by 8
Roessler, J., Zimmermann, F., Heidecker, B., Landmesser, U., & Haghikia, A. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14991 · Cited by 8
Gut Microbiota in Health and Diseases
Krga, I., & Glibetić, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00045-0 · Cited by 8
Zhang, Y., Zhu, Y., Li, M., Zhang, M., Shou, D., & Tong, P. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00374-x · Cited by 9
Wu, K., Yang, X. F., Zhang, T., Bai, Y., & Yan, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-02824-9 · Cited by 11
Cornò, M. D., Aureli, A., Varano, B., & Conti, L. (2026) · Biomolecules · doi:10.3390/biom16020226 · Cited by 8
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes
Guardiola, M., Rehues, P., Amigó, N., Arrieta, F., Botana, M., Gimeno-Orna, J. A., Girona, J., Martínez‐Montoro, J. I., Ortega, E., Pérez, A., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14214 · Cited by 7
Effects of ruminal lipopolysaccharide exposure on primary bovine ruminal epithelial cells
Sarmikasoglou, E., Chu, L., Yue, F., & Faciola, A. P. (2023) · Journal of Dairy Science · doi:10.3168/jds.2023-23736 · Cited by 6
Nocella, C., Mezzaroma, I., Cammisotto, V., Castellani, V., Milito, C., Rugova, A., Frati, G., Pignatelli, P., Violi, F., Pastori, D., et al. (2021) · HIV Medicine · doi:10.1111/hiv.13059 · Cited by 6
Self-citationState of the gut microbiota in patients with chronic heart failure
Khazova, E. V., & Дамировна, С. Д. (2023) · Medical news of the North Caucasus · doi:10.14300/mnnc.2023.18024 · Cited by 6
Dietary interventions in the management of atrial fibrillation
Nabil, M. A., Rychlik, L., Nicholson, A., Cheung, P. W., Olsovsky, G., Molden, J., Tripuraneni, A., Hajivandi, S.-S., & Banchs, J. E. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1418059 · Cited by 6
Sadowski, M., Ząbczyk, M., & Undas, A. (2024) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-024-02980-5 · Cited by 5
Intestinal Microbiomics in Physiological and Pathological Conditions
Ionescu, R. F., Cozma, E. C., Enache, R. M., Creţoiu, S. M., Iancu, M., Mandea, M., Profir, M., Roşu, O. A., & Gașpar, B. S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110642 · Cited by 5
How Different Are the Influences of Mediterranean and Japanese Diets on the Gut Microbiome?
Moriki, D., Koumpagioti, D., Francino, M. P., Rufián‐Henares, J. Á., Kalogiannis, M., Priftis, K. Ν., & Douros, K. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303261069231124092259 · Cited by 4
Atrial fibrillation and the gut microbiota: is there a link?
Zor’kina, M. A., Skirdenko, Y. P., Горбенко, А. В., Николаев, Н. А., & Andreev, K. A. (2022) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202225051110 · Cited by 5
Bucci, T., Ames, P. R. J., Cammisotto, V., Cardamone, C., Ciampa, A., Mangoni, B., Triggiani, M., Carnevale, R., Lip, G. Y. H., Pastori, D., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.10.006 · Cited by 5
Self-citationHeart Failure and Cognitive Impairment Through the Lens of the Gut Microbiome: A Narrative Review
Rahmani, A. R., Madani, S. A., Aminov, E., Gogokhia, L., Bench, T. J., & Kalogeropoulos, A. P. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120595 · Cited by 4
Blake, S. M., Baroni, L., Blake, C. P., Harding, T., Piboolnurak, P., Harding, M., & Grant, W. B. (2024) · Journal of Brain Sciences · doi:10.18488/83.v7i1.3801 · Cited by 4
Lin, S., Zhang, H., Wang, X., Lin, T., Chen, Z., Liu, J., & Wang, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.756976 · Cited by 4
Akbulut, U. E., Işık, İ. A., Atalay, A., & Topal, İ. (2021) · Eastern Mediterranean Health Journal · doi:10.26719/2021.27.6.587 · Cited by 4
Ahmed, L. A., & Al‐Massri, K. F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178210 · Cited by 3
Xu, H., Zhou, J., Ye, F., & Gao, Y. (2024) · Frontiers in Surgery · doi:10.3389/fsurg.2024.1404450 · Cited by 3
Brar, A. S., Vemula, S. L., Yanamaladoddi, V. R., Sodhi, S. S., Hatwal, J., Sohal, A., & Batta, A. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i6.107386 · Cited by 5
Drug-gut Microbiome Interaction in Atherosclerosis Therapeutics
Zhang, H.-J., Wang, Y., & Jiang, J. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230410094806 · Cited by 3
Modulating Cardiac-Gut Microbiome Interaction Post-Myocardial Infarction with Engineered BacteriaPreprint
Madaan, T., Nieman, M. L., Rakheja, T., Siddiqui, N., Gherardini, D., Sertorio, M. G., Kamble, N. S., Thomas, S. C., Hartman, A., Koch, S. E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.10.664025 · Cited by 4
Li, Z., & Zhang, G. Q. (2026) · European journal of medical research · doi:10.1186/s40001-026-04401-0 · Cited by 2
Tan, H.-Y., Yong, Y.-K., Ng, C. S., Vimali, J., Mohamed, R., Murugesan, A., Velu, V., Larsson, M., & Shankar, E. M. (2021) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2021041408 · Cited by 2
Ren, H., Wang, Z., Li, Y., & Liu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27552 · Cited by 2
Cardiometabolic disease risk in gorillas is associated with altered gut microbial metabolism
Davison, S., Mascellani, A., Ward, Z., Sackett, A., Stryková, A., Jaimes, J. D. C., Travis, D. A., Clayton, J. B., Murphy, H. W., Danforth, M. D., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00664-3 · Cited by 3
Jones, D. J., Morrison, D. J., Gray, S. R., Ozanne, S. E., Celis-Morales, C. A., Jain, M., Mattin, L. R., Gittins, M., Alkhedhairi, S., Dorling, J. L., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1572867 · Cited by 3
Nikiforov, N. G., Chegodaev, Y. S., Verkhova, S. S., Pudova, E. A., Popov, M. A., Tvorogova, A. V., Zhuravlev, A. D., Maslennikov, R. A., Snezhkina, A. V., Kudryavtseva, A. V., et al. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf060 · Cited by 2
Age-Related Changes in the Gut Microbiota Promote Atrial FibrillationPreprint
Zhang, Y., Zhang, S., Li, B., Luo, Y., Gong, Y., Jin, X., Zhang, J., Zhou, Y., Zhuo, X., Wang, Z., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-51069/v1 · Cited by 2
Jalalzadeh, M., Nasli‐Esfahani, E., Montazer, M., Geravand, F., Seyedmahalleh, M. H., Mahmoodi, M., & Azadbakht, L. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01427-1 · Cited by 1
Gut microbiota: contributing to high CVD prevalence in people living with schizophrenia?
Fu, C., Zhang, X., Qian, Y., Wang, X., Chen, X., Zeng, J. S., Zhang, N., Wang, L., Li, M., Li, Z., et al. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02103-y · Cited by 1
Wei, Z., Li, Z., & Quan, N. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1702207 · Cited by 1
Gut microbiota, sleep quality, and cognitive function in adults: A systematic review
Varpaei, H. A., Robbins, L. B., Reeves, M. J., Deka, P., Mowbray, F., & Quan, S. F. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.108834 · Cited by 2
Wang, C., Xu, Z., Wang, P., Zhang, Q., & Xiang, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1787393 · Cited by 2
González-Cidad, A., García-Moncó, J. C., & Román, G. C. (2026) · Medicina · doi:10.3390/medicina62040696 · Cited by 1
Da, S., Gao, H., Wang, T., Wei, Q., Liu, A., & Ren, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1789194 · Cited by 1
Lactobacillus shapes LPS-reservoir modules within the gut microbiota to mitigate atrial fibrillation
Wang, X. Y., Wang, X., Xu, S., Zheng, J., Pang, Y., Cheng, T., 韩瑞琴, Zhao, W., & Huang, Z. (2026) · mBio · doi:10.1128/mbio.00741-26 · Cited by 1
Kumar, M. K. P., Iyer, K. S., Shahi, S. K., Garay, J. A. R., Mangalam, A. K., & Dayal, S. (2026) · GeroScience · doi:10.1007/s11357-026-02336-2 · Cited by 1
Arenas‐Montes, J., García-Fernández, H., Alcala-Diaz, J. F., Boughanem, H., Allais, A., Gutierrez-Mariscal, F. M., Larriva, A. P. A.-D., Ojeda‐Rodríguez, A., Malagón, M. M., Priego‐Capote, F., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101323 · Cited by 1
The gut–heart axis in cardio-oncology
Chan, N. S. L., Cross, C., Bowen, J., Prestidge, C. A., Ryan, F. J., Dorraki, M., Liyanage, S., Sharma, S., Pathy, R., Bursill, C. A., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag146 · Cited by 1
Mohammadzadeh, M., Söğüt, M. Ü., Fazlzadeh, A., & Çelik, M. N. (2026) · Current Nutrition Reports · doi:10.1007/s13668-026-00795-9 · Cited by 1
Potential role of gut microbiota in cardiac arrhythmias
Goel, R., Singh, G., & Pepine, C. J. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100557 · Cited by 2
Gut Dysbiosis in Arterial Hypertension
Alves, J. L. D. B., de Souza, E. L., Cruz, J. C., Balarini, C. M., Magnani, M., Vidal, H., & Braga, V. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00025-7
山下, 智., & Hirata, K. (2022) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.31.0_63
Review Article: Gut Microbiota as Biological Regulators for Human Health
Ghoniem, G. A., Rabie, M., Anees, F. R., & Gabr, S. A. (2022) · Journal of Food and Dairy Sciences · doi:10.21608/jfds.2022.145915.1063 · Cited by 1
Popovici, M., Loffredo, L., Ivanov, V., Popovici, I., Ciobanu, L., Munteanu, M., Popovici, I., & Cobeţ, V. (2023) · Bulletin of the Academy of Sciences of Moldova Medical Sciences · doi:10.52692/1857-0011.2023.1-75.01
Gut Microbiota Links With Disease
Ishiguro, E. E., Haskey, N., & Campbell, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91387-4.00009-0
Therapeutic Interventions in Psycho-Neuro-Endocrino-Immunology (PNEI)
Toljan, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-33013-1_16
Effect of Diet Patterns in the Prevention of Alzheimer’s Disease
Cosio, D. S., Rodriguez, S., Jayakumar, A. R., & Paidas, M. J. (2023) · Nutritional neurosciences · doi:10.1007/978-981-99-0677-2_13
Research Progress of Lipopolysaccharides in Atrial Fibrillation
陈, 先. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122822
Liu, C.-H., Wen, Z., Huo, Y., Lin, C., Yang, H., & Tsai, C. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176695
Gut Microbiome and Metabolite Alterations in Atrial FibrillationPreprint
Gutmann, F., Börschel, C. S., Markó, L., Löber, U., Bartolomaeus, T. U. P., Jovanović, N. D., Zeller, T., Nauck, M., Friedrich, N., Henning, A., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5040703
Jawamis, A., Al-Domi, H. A., & Sarayreh, N. A. (2026) · Nutrition · doi:10.1016/j.nut.2026.113119
The “Movie Theater” Study: Acute Cardiometabolic Effects of a Cinema-Style Meal
Schifferer, J. K., Quirk, A. R., Higgins, M. E., Fruit, S. E., Keirns, N. G., & Keirns, B. H. (2026) · Metabolites · doi:10.3390/metabo16020139
Exposition aux endotoxines : influence de l'alimentation et rôle dans le vieillissement cognitif
André, P. (2020) · theses.fr (ABES) · doi:10.70675/ea1360c2zd962z46f5zaabfzcbc15c0efc25
Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk
Shayan, S. K., Abbood, R. S., Al-Taie, S. F., Nataj, P. G., Khamdamjanovna, M. M., Aminnezhad, S., Boushehri, Y. G., Sindorovich, J. J., Sinehsepehr, A., Zare, F., et al. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70265 · Cited by 1
Casademont‐Roca, A., Keshtkar, S., Kersten, S., Tomassen, M. M. M., Steegenga, W. T., Hooiveld, G. J. E. J., & Mes, J. J. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107375
Wei, Z., Luo, X., Xia, Y., Cui, M., An, P., Luo, J., & Luo, Y. (2026) · Antioxidants · doi:10.3390/antiox15070831
The impact of climatic extreme temperatures on gut microbiome-mediated cardio-metabolic health
Shukla, A., Rughwani, D., Aditya, A. K., & Ray, A. K. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128877
CVD Emerging Risk Factors: Gut Microbiota
Abais‐Battad, J. M. (2026) · Physiology in health and disease · doi:10.1007/978-3-032-26472-5_16
Szukiewicz, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167287
Studies on obesity-related atrial fibrillation in the past 20 years
Du, B., Yao, J., Niu, Y., Yuan, C., Luan, Y., Zhang, X., Song, Y., Hu, Y., & Li, J. (2026) · Medicine · doi:10.1097/md.0000000000050429
PCSK9 and Atrial Fibrillation: A New Perspective on an Old Problem
Sahebkar, A., Almahmeed, W. A., Kesharwani, P., & Jamialahmadi, T. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/7328020
Metadata
- Authors
- Pastori, D., Carnevale, R., Nocella, C., Novo, M., Santulli, M., Cammisotto, V., Menichelli, D., Pignatelli, P., & Violi, F.
- Affiliations
- Sapienza University of Rome (IT)
- Corresponding author
- Violi, Francesco
- ORCID
- Venue
- Journal of the American Heart Association
- Published
- 2017-11-06
- Volume
- 6
- Issue
- 6
- ISSN
- 2047-9980 (ISSN-L)
- PMC
- PMC5669181
- OpenAlex
- W2623414143
- Cited by
- 182
- References
- 45
- Citations by year
- 2026: 22 · 2025: 18 · 2024: 30 · 2023: 28 · 2022: 27 · 2021: 24 · 2020: 12 · 2019: 11 · 2018: 7 · 2017: 3
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Journal of the American Heart Association (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- atrial fibrillation, major adverse cardiovascular events, Mediterranean diet adherence, gut microbiota, atherothrombosis, 11-dehydrothromboxane B2, vitamin K antagonists, Fabaceae, fruits, LDL cholesterol, cerebrovascular events, cardiac events, serum biomarkers, risk prediction, vitamin B12 deficiency, folate deficiency, vitamin K deficiency, scurvy, vitamin E deficiency, vitamin A deficiency
- MeSH terms
- Gastrointestinal Microbiome, Aged, Aged, 80 and over, Anticoagulants, Atrial Fibrillation, Bacteria, Cerebrovascular Disorders, Female, Humans, Intestines, Lipopolysaccharides, Male, Patient Compliance, Prospective Studies, Risk Factors, Rome, Time Factors, Vitamin K, Biomarkers, Platelet Activation, Treatment Outcome, Myocardial Ischemia, Diet, Mediterranean, Kaplan-Meier Estimate, Protective Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
